Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000390779 | SCV000336082 | uncertain significance | not provided | 2015-10-02 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001086060 | SCV001090265 | likely benign | Neuronal ceroid lipofuscinosis | 2024-01-14 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000390779 | SCV002038840 | uncertain significance | not provided | 2021-12-13 | criteria provided, single submitter | clinical testing | In silico analysis supports that this variant does not alter splicing; Has not been previously published as pathogenic or benign to our knowledge |
Natera, |
RCV001086060 | SCV001454737 | uncertain significance | Neuronal ceroid lipofuscinosis | 2019-10-28 | no assertion criteria provided | clinical testing |